Home Federal Bank of Tennessee’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Buy
9,159
+2,800
+44% +$161K 0.11% 73
2026
Q1
$386K Buy
+6,359
New +$371K 0.1% 74
2020
Q1
Sell
-3,158
Closed -$203K 63
2019
Q4
$203K Buy
+3,158
New +$181K 0.09% 67
2017
Q4
Sell
-3,158
Closed -$202K 67
2017
Q3
$202K Buy
+3,158
New +$184K 0.1% 61
2017
Q2
Sell
-6,356
Closed -$345K 63
2017
Q1
$345K Buy
6,356
+2,341
+58% +$128K 0.19% 55
2016
Q4
$234K Buy
4,015
+100
+3% +$5.47K 0.13% 57
2016
Q3
$211K Hold
3,915
0.12% 58
2016
Q2
$288K Hold
3,915
0.17% 55
2016
Q1
$250K Hold
3,915
0.16% 59
2015
Q4
$270K Buy
+3,915
New +$259K 0.18% 57

Other funds holding BMY

Home Federal Bank of Tennessee's BMY Position: Q2 2026 in Review

Home Federal Bank of Tennessee increased its Bristol-Myers Squibb (BMY) stake by 44% in Q2 2026, buying an estimated $161K and bringing the position to 9,159 shares worth $528K. The position accounts for 0.11% of the portfolio, ranked #73.

Home Federal Bank of Tennessee first reported a position in BMY in Q4 2015 and has held it in 10 quarters since. 1,993 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Home Federal Bank of Tennessee held 9,159 shares of Bristol-Myers Squibb worth $528K as of Q2 2026.
  • Home Federal Bank of Tennessee bought 2,800 Bristol-Myers Squibb shares in Q2 2026, an estimated $161K.
  • Bristol-Myers Squibb made up 0.11% of Home Federal Bank of Tennessee's portfolio in Q2 2026, its #73 holding.
  • Home Federal Bank of Tennessee first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 10 quarters since.
  • 1,993 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Home Federal Bank of Tennessee's 13F filing for Q2 2026, filed 15 Jul 2026.